Loading...
XSTO
NICA
Market cap10mUSD
Jul 11, Last price  
1.14SEK
1D
-3.39%
1Q
37.02%
Jan 2017
-92.75%
IPO
-93.49%
Name

Nanologica AB (publ)

Chart & Performance

D1W1MN
P/E
—
P/S
6.93
EPS
—
Div Yield, %
—
Shrs. gr., 5y
28.42%
Rev. gr., 5y
7.29%
Revenues
15m
+907.48%
3,563,9174,739,2641,645,3003,262,6572,000,3872,599,8404,145,28310,226,79716,135,00012,914,0001,555,0001,443,00014,538,000
Net income
-66m
L-12.68%
-5,035,778-10,064,310-14,723,760-14,290,972-22,459,617-20,095,140-20,889,107-21,473,191-24,826,000-50,132,000-55,090,000-75,157,000-65,629,000
CFO
-81m
L+125.21%
000-13,947,096-23,188,800-23,193,529-11,705,322-11,522,273-43,340,000-46,493,000-45,219,000-35,848,000-80,734,000

Profile

Nanologica AB (publ), a nanotechnology company, develops nanoporous silica for applications in the life science industry. The company offers nanoporous silica particles for drug development and chromatography separation. It provides NLAB Silica, a technology platform for drug delivery; NLAB Spiro, an inhalation platform for pulmonary drug delivery; SVEA (U)HPLC analytical columns; and preparative chromatography. Nanologica AB (publ) was founded in 2004 and is based in Södertälje, Sweden.
URL
https://www.nanologica.com/
IPO date
Oct 30, 2015
Employees
19
Domiciled in
SE
Incorporated in
SE

Valuation

Title
SEK in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
14,538
907.48%
1,443
-7.20%
1,555
-87.96%
Cost of revenue
10,245
8,820
16,601
Unusual Expense (Income)
NOPBT
4,293
(7,377)
(15,046)
NOPBT Margin
29.53%
Operating Taxes
35
(141)
Tax Rate
0.82%
NOPAT
4,258
(7,377)
(14,905)
Net income
(65,629)
-12.68%
(75,157)
36.43%
(55,090)
9.89%
Dividends
Dividend yield
Proceeds from repurchase of equity
131,490
100
79,803
BB yield
Debt
Debt current
50,684
530
4,026
Long-term debt
3,412
802
4,025
Deferred revenue
Other long-term liabilities
24
67,328
67,174
Net debt
5,666
(8,722)
(62,271)
Cash flow
Cash from operating activities
(80,734)
(35,848)
(45,219)
CAPEX
(262)
(1,756)
(8,558)
Cash from investing activities
(742)
(20,353)
(7,142)
Cash from financing activities
120,228
(4,086)
111,697
FCF
(24,255)
18,294
(10,441)
Balance
Cash
48,430
10,054
70,322
Long term investments
Excess cash
47,703
9,982
70,244
Stockholders' equity
(368,060)
(310,193)
(235,037)
Invested Capital
493,138
376,289
380,061
ROIC
0.98%
ROCE
3.43%
EV
Common stock shares outstanding
58,905
36,631
30,427
Price
Market cap
EV
EBITDA
18,412
7,102
(3,184)
EV/EBITDA
Interest
6,693
5,712
5,009
Interest/NOPBT
155.90%